New breast cancer drug defeats the Ras genes notorious for causing many types of cancer

(Virginia Commonwealth University) A new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected process.